Prevalence of thyroid cancer in multinodular goiter versus single nodule

A systematic review and meta-Analysis

Juan Brito Campana, Andres J. Yarur, Larry J. Prokop, Bryan McIver, Mohammad H Murad, Victor Manuel Montori

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Whether the prevalence of thyroid cancer is different in thyroid glands with a single nodule (SN) versus multinodular goiter (MNG) remains uncertain. Therefore, a meta-Analysis was performed to evaluate the extant literature on the comparative prevalence of thyroid cancer in SN compared with MNG. Methods: We searched MEDLINE, EMBASE, Scopus, Cochrane Central, and reference list for selected observational, cross-sectional, and longitudinal studies evaluating thyroid cancer in SN and MNG. Toxic nodules were not included in the analysis. Two reviewers working independently extracted descriptive, methodological and outcome data from each study with consensus resolution of discrepancies. Meta-Analytic estimates of treatment effects were generated using a random-effect model. Results: Fourteen studies encompassing 23565 patients with MNG and 20723 patients with SN were eligible for inclusion. Most eligible studies were at a moderate risk of bias. MNGs were associated with a lower risk of thyroid cancer than SN (pooled odds ratio 0.8 [95% confidence interval 0.67-0.96]; I2=35%). Subgroup analysis suggested that this difference depends on the inclusion of studies conducted outside the United States (odds ratio 0.71 [95% confidence interval 0.60-0.83]; I2=11%). Conclusions: Thyroid cancer may be less frequent in MNG compared to SN, particularly outside the United States and perhaps in iodine-deficient areas.

Original languageEnglish (US)
Pages (from-to)449-455
Number of pages7
JournalThyroid
Volume23
Issue number4
DOIs
StatePublished - Apr 1 2013

Fingerprint

Goiter
Thyroid Neoplasms
Meta-Analysis
Odds Ratio
Confidence Intervals
Poisons
MEDLINE
Iodine
Longitudinal Studies
Thyroid Gland
Cross-Sectional Studies

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Prevalence of thyroid cancer in multinodular goiter versus single nodule : A systematic review and meta-Analysis. / Brito Campana, Juan; Yarur, Andres J.; Prokop, Larry J.; McIver, Bryan; Murad, Mohammad H; Montori, Victor Manuel.

In: Thyroid, Vol. 23, No. 4, 01.04.2013, p. 449-455.

Research output: Contribution to journalArticle

@article{921232de869d41b59fe46881be377083,
title = "Prevalence of thyroid cancer in multinodular goiter versus single nodule: A systematic review and meta-Analysis",
abstract = "Background: Whether the prevalence of thyroid cancer is different in thyroid glands with a single nodule (SN) versus multinodular goiter (MNG) remains uncertain. Therefore, a meta-Analysis was performed to evaluate the extant literature on the comparative prevalence of thyroid cancer in SN compared with MNG. Methods: We searched MEDLINE, EMBASE, Scopus, Cochrane Central, and reference list for selected observational, cross-sectional, and longitudinal studies evaluating thyroid cancer in SN and MNG. Toxic nodules were not included in the analysis. Two reviewers working independently extracted descriptive, methodological and outcome data from each study with consensus resolution of discrepancies. Meta-Analytic estimates of treatment effects were generated using a random-effect model. Results: Fourteen studies encompassing 23565 patients with MNG and 20723 patients with SN were eligible for inclusion. Most eligible studies were at a moderate risk of bias. MNGs were associated with a lower risk of thyroid cancer than SN (pooled odds ratio 0.8 [95{\%} confidence interval 0.67-0.96]; I2=35{\%}). Subgroup analysis suggested that this difference depends on the inclusion of studies conducted outside the United States (odds ratio 0.71 [95{\%} confidence interval 0.60-0.83]; I2=11{\%}). Conclusions: Thyroid cancer may be less frequent in MNG compared to SN, particularly outside the United States and perhaps in iodine-deficient areas.",
author = "{Brito Campana}, Juan and Yarur, {Andres J.} and Prokop, {Larry J.} and Bryan McIver and Murad, {Mohammad H} and Montori, {Victor Manuel}",
year = "2013",
month = "4",
day = "1",
doi = "10.1089/thy.2012.0156",
language = "English (US)",
volume = "23",
pages = "449--455",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Prevalence of thyroid cancer in multinodular goiter versus single nodule

T2 - A systematic review and meta-Analysis

AU - Brito Campana, Juan

AU - Yarur, Andres J.

AU - Prokop, Larry J.

AU - McIver, Bryan

AU - Murad, Mohammad H

AU - Montori, Victor Manuel

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Background: Whether the prevalence of thyroid cancer is different in thyroid glands with a single nodule (SN) versus multinodular goiter (MNG) remains uncertain. Therefore, a meta-Analysis was performed to evaluate the extant literature on the comparative prevalence of thyroid cancer in SN compared with MNG. Methods: We searched MEDLINE, EMBASE, Scopus, Cochrane Central, and reference list for selected observational, cross-sectional, and longitudinal studies evaluating thyroid cancer in SN and MNG. Toxic nodules were not included in the analysis. Two reviewers working independently extracted descriptive, methodological and outcome data from each study with consensus resolution of discrepancies. Meta-Analytic estimates of treatment effects were generated using a random-effect model. Results: Fourteen studies encompassing 23565 patients with MNG and 20723 patients with SN were eligible for inclusion. Most eligible studies were at a moderate risk of bias. MNGs were associated with a lower risk of thyroid cancer than SN (pooled odds ratio 0.8 [95% confidence interval 0.67-0.96]; I2=35%). Subgroup analysis suggested that this difference depends on the inclusion of studies conducted outside the United States (odds ratio 0.71 [95% confidence interval 0.60-0.83]; I2=11%). Conclusions: Thyroid cancer may be less frequent in MNG compared to SN, particularly outside the United States and perhaps in iodine-deficient areas.

AB - Background: Whether the prevalence of thyroid cancer is different in thyroid glands with a single nodule (SN) versus multinodular goiter (MNG) remains uncertain. Therefore, a meta-Analysis was performed to evaluate the extant literature on the comparative prevalence of thyroid cancer in SN compared with MNG. Methods: We searched MEDLINE, EMBASE, Scopus, Cochrane Central, and reference list for selected observational, cross-sectional, and longitudinal studies evaluating thyroid cancer in SN and MNG. Toxic nodules were not included in the analysis. Two reviewers working independently extracted descriptive, methodological and outcome data from each study with consensus resolution of discrepancies. Meta-Analytic estimates of treatment effects were generated using a random-effect model. Results: Fourteen studies encompassing 23565 patients with MNG and 20723 patients with SN were eligible for inclusion. Most eligible studies were at a moderate risk of bias. MNGs were associated with a lower risk of thyroid cancer than SN (pooled odds ratio 0.8 [95% confidence interval 0.67-0.96]; I2=35%). Subgroup analysis suggested that this difference depends on the inclusion of studies conducted outside the United States (odds ratio 0.71 [95% confidence interval 0.60-0.83]; I2=11%). Conclusions: Thyroid cancer may be less frequent in MNG compared to SN, particularly outside the United States and perhaps in iodine-deficient areas.

UR - http://www.scopus.com/inward/record.url?scp=84875724306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875724306&partnerID=8YFLogxK

U2 - 10.1089/thy.2012.0156

DO - 10.1089/thy.2012.0156

M3 - Article

VL - 23

SP - 449

EP - 455

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 4

ER -